COTE JENNIFER (Interim CFO) received a stock award from HARVARD BIOSCIENCE INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 3/7/2024ACC: 0001193805-24-000334
Officer· Interim CFO
Since Jan 2023
+61.68K
Net shares
Net buyer
$40.8K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
71.60K acquired · 9.92K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+35.80K
Price / share
—
Trade value
—
% of position
33.4%
3/5/2024
107.06K→142.86K
Common Stock
Direct
Shares
+35.80K
Price / share
—
Trade value
—
% of position
25.1%
3/5/2024
142.86K→178.66K
Common Stock
Direct
Shares
−9.92K
Price / share
$4.11
Trade value
$40.77K
% of position
5.6%
3/6/2024
178.66K→168.74K
Total
Net shares
+61.68K
Net value
-$40.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2024 | A · Award | +35.80K | — | — | 33.4% | 107.06K | 142.86K |
| Common Stock Direct | 3/5/2024 | A · Award | +35.80K | — | — | 25.1% | 142.86K | 178.66K |
| Common Stock Direct | 3/6/2024 | F · Tax Withholding | −9.92K | $4.11 | $40.77K | 5.6% | 178.66K | 168.74K |
| Total | +61.68K | -$40.77K | ||||||
Derivative Transactions0
No derivative transactions reported